Related Experiment Video
Updated: Jun 17, 2026
10:35
Multimodal Imaging and Spectroscopy Fiber-bundle Microendoscopy Platform for Non-invasive, In Vivo Tissue Analysis
Published on: October 17, 2016
Characterization of metabolic differences between benign and malignant tumors: high-spectral-resolution diffuse
Shwayta Kukreti1, Albert E Cerussi, Wendy Tanamai
1Beckman Laser Institute, University of California, Irvine, CA 92612, USA.
Radiology
|December 25, 2009
Summary
A novel near-infrared spectroscopic method accurately distinguishes malignant from benign breast tumors. This technique identifies localized tumor biomarkers, improving diagnostic capabilities for breast cancer detection.
Area of Science:
- Biomedical Optics
- Medical Imaging
- Spectroscopy
Background:
- Breast cancer diagnosis relies on accurate differentiation between benign and malignant lesions.
- Current imaging techniques may have limitations in specificity.
- Near-infrared spectroscopy offers a non-invasive approach for tissue analysis.
Purpose of the Study:
- To develop a near-infrared spectroscopic method for identifying breast cancer biomarkers.
- To evaluate the method's ability to distinguish between benign and malignant breast lesions.
Main Methods:
- Utilized self-referencing differential spectroscopy (SRDS) analysis.
- Acquired diffuse optical spectroscopy imaging data in the 650-1000 nm wavelength range.
- Applied SRDS to analyze 40 breast lesions (22 malignant, 18 benign) in 60 subjects.
Main Results:
- Achieved high diagnostic accuracy: sensitivity 91%, specificity 94%.
- Positive predictive value was 95%, and negative predictive value was 89%.
- Discrimination analysis successfully separated malignant from benign tumors based on spectroscopic signatures.
Conclusions:
- The SRDS method effectively identifies localized tumor biomarkers specific to the pathologic state.
- This spectroscopic approach shows promise for non-invasive breast cancer diagnosis.
